by Shari Basch | Oct 23, 2023 | Company, Management Team
Dr. Han’s career in biotechnology and pharmaceutical industry spans over 25 years, with 19 years in ophthalmology. He brings experience in early and late-stage drug development in both anterior and posterior ophthalmology. He has a...
by Samuel Nee | Oct 16, 2023 | Company, Management Team
Mark O’Neill was appointed Vice President CMC in January 2022. Mr. O’Neill was most recently head of Process Development for Avexis Gene therapies where he orchestrated all product development and technical operations activities pertaining to the startup and...
by Samuel Nee | Sep 15, 2023 | Company, Management Team
Karen Adams was appointed Vice President Finance in May 2021 and Company Secretary in June 2021. Karen is accountable directly to the board, through the chair, on all matters to do with the proper functioning of Opthea’s board. Prior to joining Opthea, Karen was the...
by Samuel Nee | Aug 16, 2023 | Company, Management Team
Bruno joined Opthea in July 2022 and leads Global Clinical Operations. Bruno is former Sr. Vice President of Development Operations at Eidos Therapeutics, a BridgeBio company in San Francisco, CA. He also served as Vice President of Clinical Operations at BioMarin...
by Shari Basch | Jul 8, 2023 | Company, Management Team
Dr. Li is an accomplished regulatory affairs professional with over three decades of experience in pharmaceutical development and regulatory affairs. She has held leadership positions at Novartis, Alcon, and Bausch & Lomb, where her contributions encompass health...